The hospital oversees treatment of about 80 cancer patients and is anticipating a shortage of cancer drugs — including carboplatin and cisplatin, which are used to treat tumors — to persist for several months. The hospital’s cancer center recently requested 800 milligrams of cisplatin from regional vendors, though that is expected to last for only a week.
“We’ve developed a number of mitigation strategies to minimize that impact and risk to each of these very vulnerable patients,” Tod Morris, MD, an oncology specialist at Tallahassee Memorial, told the news station. “We’re going to do everything we can to provide the highest quality outcomes in this difficult situation.”
Across the U.S., near record drug shortages are causing treatment delays for thousands of patients with cancer and other diseases, according to The New York Times.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
